No nephropathy in Type 2 diabetic patient with POEMS syndrome with an elevated plasma VEGF

被引:4
作者
Baba, T
Osterby, R
Neugebauer-Baba, S
Nozawa, Y
Watanabe, T
Sakurai, K
Katoh, T
Watanabe, T
机构
[1] Dominikus Hosp, Dept Angiol, Dusseldorf, Germany
[2] Aarhus Kommune Hosp, Inst Pathol, Electron Microscopy Lab, DK-8000 Aarhus, Denmark
[3] Fukushima Med Univ, Dept Neurol, Fukushima, Japan
[4] Fukushima Med Univ, Dept Pathol 1, Fukushima, Japan
[5] Fukushima Med Univ, Dept Internal Med 3, Fukushima, Japan
关键词
Crow-Fukase syndrome; diabetic nephropathy; POEMS syndrome; vascular endothelia growth factor; VEGF;
D O I
10.1111/j.1464-5491.2004.01094.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) is considered to have a role in the pathogenesis of diabetic retinopathy. Recent experimental observations that anti-VEGF neutralizing antibody fully abolished the hyperfiltration and the increase in urinary albumin excretion suggested the contribution of VEGF to the development of diabetic nephropathy, as well. Here, we present a case of POEMS (Crow-Fukase) syndrome with Type 2 diabetes, which was associated with elevated plasma VEGF level, but no sign of diabetic nephropathy. The findings obtained from this case did not support the hypothesis that VEGF may enhance the development of diabetic nephropathy.
引用
收藏
页码:292 / 294
页数:3
相关论文
共 11 条
  • [1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [2] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
  • [3] UNILATERAL NODULAR DIABETIC GLOMERULOSCLEROSIS - RECURRENCE OF AN EXPERIMENT OF NATURE
    BERONIADE, VC
    LEFEBVRE, R
    FALARDEAU, P
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1987, 7 (01) : 55 - 59
  • [4] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [5] De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
  • [6] POEMS syndrome: definitions and long-term outcome
    Dispenzieri, A
    Kyle, RA
    Lacy, MQ
    Rajkumar, SV
    Therneau, TM
    Larson, DR
    Greipp, PR
    Witzig, TE
    Basu, R
    Suarez, GA
    Fonseca, R
    Lust, JA
    Gertz, MA
    [J]. BLOOD, 2003, 101 (07) : 2496 - 2506
  • [7] Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease
    Flyvbjerg, A
    [J]. DIABETOLOGIA, 2000, 43 (10) : 1205 - 1223
  • [8] VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN
    LEUNG, DW
    CACHIANES, G
    KUANG, WJ
    GOEDDEL, DV
    FERRARA, N
    [J]. SCIENCE, 1989, 246 (4935) : 1306 - 1309
  • [9] THE CROW-FUKASE SYNDROME - A STUDY OF 102 CASES IN JAPAN
    NAKANISHI, T
    SOBUE, I
    TOYOKURA, Y
    NISHITANI, H
    KUROIWA, Y
    SATOYOSHI, E
    TSUBAKI, T
    IGATA, A
    OZAKI, Y
    [J]. NEUROLOGY, 1984, 34 (06) : 712 - 720
  • [10] FAMILIAL CLUSTERING OF DIABETIC KIDNEY-DISEASE - EVIDENCE FOR GENETIC SUSCEPTIBILITY TO DIABETIC NEPHROPATHY
    SEAQUIST, ER
    GOETZ, FC
    RICH, S
    BARBOSA, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) : 1161 - 1165